Stay updated on SAGE-547 in Severe Postpartum Depression Clinical Trial
Sign up to get notified when there's something new on the SAGE-547 in Severe Postpartum Depression Clinical Trial page.

Latest updates to the SAGE-547 in Severe Postpartum Depression Clinical Trial page
- Check4 days agoNo Change Detected
- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedMinor textual updates: a PubMed publications note is added and the revision label updated from v3.2.0 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check26 days agoChange DetectedThe government funding status notice related to NIH operations was removed from the page.SummaryDifference0.3%

- Check40 days agoChange DetectedThe page shows a recent update to Study Record Dates (Last Update Posted 2025-10-14) with no changes to core study content such as title, sponsor, eligibility criteria, or locations. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check55 days agoChange DetectedCore brand/name update from Sage Therapeutics to Supernus Pharmaceuticals, with new date references and an updated timestamp label.SummaryDifference1%

- Check69 days agoChange DetectedMajor update to operational notice and version number: moving from v3.1.0 to v3.2.0 with a government-operating-status disclaimer.SummaryDifference2%

- Check76 days agoChange DetectedMajor change: page now shows Revision: v3.1.0 and removes several drug-safety topics; indicates a content reorganization with version update rather than additions of new substantive information.SummaryDifference0.3%

Stay in the know with updates to SAGE-547 in Severe Postpartum Depression Clinical Trial
Enter your email address, and we'll notify you when there's something new on the SAGE-547 in Severe Postpartum Depression Clinical Trial page.